
Renovare Environmental, Inc., through its subsidiaries, provides environmental management solutions worldwide. The company's suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. It markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and Mechanical Biological Treatment technology to process waste at the municipal or enterprise level. The company serves retail, healthcare, government, hospitality, education, food service, and other sectors, as well as food distributors, convention centers, hotels, restaurants, stadiums, municipalities, and academic institutions. The company was formerly known as BioHiTech Global, Inc. and changed its name to Renovare Environmental, Inc. in December 2021. Renovare Environmental, Inc. is headquartered in Chestnut Ridge, New York.
Renovare Environmental, Inc. trades as RENO on OTC. The company is classified in Industrials / Industrial - Pollution & Treatment Controls and reports in USD.
The current profile places the business in Industrial - Pollution & Treatment Controls. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Renovare Environmental, Inc. can be compared against peers such as Advanced Engine Technologies, Inc., EAU Technologies, Inc., GreenCell, Inc., HyreCar Inc., Isonics Corporation, OneLink Corporation.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $3,520, beta of -24.40, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
RENO currently shows total debt of N/A and beta of -24.40. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://renovareenv.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.